Compare ETD & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETD | XOMA |
|---|---|---|
| Founded | 1932 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.7M | 471.6M |
| IPO Year | 1996 | N/A |
| Metric | ETD | XOMA |
|---|---|---|
| Price | $20.81 | $41.73 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $27.00 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 482.2K | 160.2K |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 8.15% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.10 | N/A |
| Revenue | ★ $766,784,000.00 | N/A |
| Revenue This Year | N/A | $24.59 |
| Revenue Next Year | $2.73 | N/A |
| P/E Ratio | ★ $19.11 | $29.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.28 | $22.29 |
| 52 Week High | $31.41 | $42.81 |
| Indicator | ETD | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 52.24 | 63.93 |
| Support Level | $18.28 | $37.00 |
| Resistance Level | $22.89 | $42.15 |
| Average True Range (ATR) | 0.57 | 0.32 |
| MACD | 0.25 | -0.32 |
| Stochastic Oscillator | 80.13 | 31.18 |
Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.